UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus
Go back to UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus| (NYSE: UCB) | Delayed: 35.51 -0.19 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.70 | 52 Week High | $ | |||
| Open | $35.49 | 52 Week Low | $ | |||
| Day High | $35.74 | P/E | N/A | |||
| Day Low | $35.30 | EPS | $ | |||
| Volume | 685,292 | |||||

